CDK4 and breast carcinoma: To interrogate the biological effect of downregulating these proteins, we knocked down CDK4 and/or CDK6 in two ER+ breast cancer cell lines, MCF7 and T47D via shRNA and siRNA (Supplementary Fig. 1b,c and f).